Alerts will be sent to your verified email
Verify Email
SICL
|
Suvidha Infraestate
|
Vanta Bioscience
|
MIG Media Neurons
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.37 % | -9.14 % | n/a |
|
5yr average Equity Multiplier
|
-1.13 | 3.77 | n/a |
|
5yr Average Asset Turnover Ratio
|
0.14 | 0.14 | n/a |
|
5yr Avg Net Profit Margin
|
-9151.91 % | -22.86 % | n/a |
|
Price to Book
|
0.0 | 0.0 | n/a |
|
P/E
|
0.0 | 0.0 | n/a |
|
5yr Avg Cash Conversion Cycle
|
3868.83 Days | -2109.35 Days | n/a |
|
Inventory Days
|
1490.59 Days | 349.3 Days | n/a |
|
Days Receivable
|
0.0 | 95.72 Days | n/a |
|
Days Payable
|
13.42 Days | 977.74 Days | n/a |
|
5yr Average Interest Coverage Ratio
|
120.76 | 0.56 | n/a |
|
5yr Avg ROCE
|
-2.86 % | 1.17 % | n/a |
|
5yr Avg Operating Profit Margin
|
-7877.48 % | 16.63 % | n/a |
|
5 yr average Debt to Equity
|
-1.74 | 2.28 | n/a |
|
5yr CAGR Net Profit
|
-17.81 % | n/a | n/a |
|
5yr Average Return on Assets
|
-5.22 % | -1.51 % | n/a |
|
Shareholdings
|
|||
|
Promoter Holding
|
59.83 % | 69.36 % | n/a |
|
Share Pledged by Promoters
|
0.0 | 0.0 | n/a |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.57 % | n/a |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | n/a |
|
Suvidha Infraestate
|
Vanta Bioscience
|
MIG Media Neurons
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|